InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,118.94
(
1.49%
)

Replies to post #1920 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1920 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

11/28/20 2:41 PM

#1921 RE: DewDiligence #1920

ENTA’s enterprise value at the current share price—($42.90)—is ~$550M, based on 23.3M fully-diluted shares (#msg-159770202) and pro forma cash of $445.3M (#msg-159770118).
icon url

DewDiligence

02/10/21 2:41 PM

#1937 RE: DewDiligence #1920

ENTA’s fully-diluted* share count @12/31/20=23.9M—an increase of 0.6M since 9/30/20 (#msg-159770202).

The 23.9M figure above consists of: 20.1M basic shares on the 12/31/20 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/1177648/000156459021004983/enta-10q_20201231.htm#CONSOLIDATED_BALANCE_SHEETS ); and 3.8M options outstanding (whether or not exercisable) (ibid, page 13).

*Non-treasury method.